Drug intelligence / Profile preview

huaier polysaccharide

Development stage
Unknown
Lead developer
Qidong Gaitianli Medicines
Modality
Small Molecules
Administration
Oral, Topical, Intraperitoneal (experimental)
01

Overview

**Huaier polysaccharide** is the main bioactive component extracted from the medicinal fungus *Trametes robiniophila Murr* (Huaier), long used in traditional Chinese medicine. Huaier polysaccharide exhibits **antitumor**, **antiviral**, **immunomodulatory**, and **anti-inflammatory** properties. Its mechanisms include inhibition of tumor cell proliferation, induction of cell cycle arrest (often in the G1 phase), apoptosis via caspase pathways, impairment of DNA repair in malignant cells, inhibition of epithelial-mesenchymal transition (EMT) via autophagy, direct virus inactivation, suppression of viral attachment and entry, and immunoregulation affecting numerous immune and inflammatory pathways[1][2][4][5]. \nIt is mainly used as an adjunct in the treatment of various cancers (breast, liver, gastric, colon, melanoma, lung, prostate, fibrosarcoma), and shows benefit in psoriasis and potentially viral infections (e.g. pseudorabies virus). Notably, Huaier polysaccharide displays selective cytotoxicity towards cancer cells and low toxicity to normal cells, with a favorable safety profile in preclinical and limited clinical studies[3][4]. \nThe active polysaccharide molecule consists largely of monosaccharide subunits and may also include minor amino acids and trace elements[2][5].

Brand names
Huaier GranulesHuaierHuaier Extract
Other names
Trametes robiniophila Murr polysaccharideHuaier extractHuaier fungus polysaccharideHuaier-derived polysaccharide
02

Targets

SNAI1 (Snail family transcriptional repressor 1)MAPK12 (Mitogen-activated protein kinase 12)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)ERα36 (ER-alpha36)

Beyond the preview

Go deeper on huaier polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on huaier polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call